CLX 99.83 Clorox Company $CLX Hit a 52 week high of 100.47

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CLX 99.83 Clorox Company $CLX Hit a 52 week high of 100.47 Closing the day 11/03/14 at 99.83 +0.33 +0.33% With a day low of 98.86 and a total volume of 1,205,088.

CLX Recent Posts: http://investorshangout.com/Clorox-Company-CLX-50551/

CLX Clorox Company Recent Headline News

Company News for November 03, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:10AM CST
Companies in the News are: CLX,ITT,PNW,COL
CLX: 99.83 (+0.33), PNW: 62.25 (+0.78), ITT: 44.11 (-0.95), COL: 84.16 (+0.01)

Clorox Tops Q1 On Burt's Bees and Kingsford Charcoal
at Investor's Business Daily - Fri Oct 31, 12:21PM CDT
Burt's Bees and Kingsford charcoal helped boost Clorox's (CLX) volume in its fiscal first quarter, as the household-products company topped earnings and sales views. Earnings edged up almost 1% to $1.05 -- excluding a one-time 5-cent benefit and...
CLX: 99.83 (+0.33)

Clorox Beats Q1 Earnings Estimates, Retains FY15 Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 9:27AM CDT
The Clorox Company (CLX) started fiscal 2015 on a strong note wherein both top and bottom lines marked a year-over-year improvement and also came ahead of the Zacks Consensus Estimate.
CLX: 99.83 (+0.33), CBK: 6.33 (-0.20), HBI: 106.48 (+0.87), ARO: 2.94 (-0.07)

Clorox tops Street 1Q forecasts
Automated Insights - Fri Oct 31, 7:39AM CDT
OAKLAND, Calif. (AP) _ Clorox Co. (CLX) on Friday reported earnings of $90 million in its fiscal first quarter.
CLX: 99.83 (+0.33)

Stocks With Monthly Dividends: Chambers Street Properties
Matthew Frankel, The Motley Fool - Motley Fool - Thu Oct 30, 7:15AM CDT
Chambers Street Properties is a real estate investment trust, or REIT, that owns and operates industrial and office properties. The company leases properties to a diverse group of high-quality tenants, with the main goal of providing a steady,...
CSG: 8.22 (+0.01), AMZN: 305.72 (+0.26), JPM: 60.88 (+0.40), CLX: 99.83 (+0.33), RTN: 103.38 (-0.50)

Jim Cramer's Top Stock Picks: CLX HPQ FB PII ETN
at The Street - Thu Oct 30, 5:00AM CDT
Cramer continues to trust Facebook's Mark Zuckerberg and is a big believer in Polaris and Eaton.
ETN: 68.43 (+0.04), CLX: 99.83 (+0.33), FB: 73.88 (-1.11), HPQ: 35.86 (-0.02), PII: 150.41 (-0.45)


Grocery chain sues Clorox for price discrimination
Wisconsin State Journal - Wed Oct 29, 4:17PM CDT
MADISON, Wis. (AP) — The Woodman's grocery store chain is suing Clorox Corp., alleging price discrimination.
CLX: 99.83 (+0.33), COST: 134.27 (+0.90)

Will Clorox (CLX) Post a Surprise This Earnings Season? - Analyst Blog
Vrishali Bagree - Zacks Investment Research - Tue Oct 28, 6:30PM CDT
Clorox (CLX) is slated to report its first-quarter fiscal 2015 results on Oct 31.
LB: 72.44 (+0.32), KR: 56.44 (+0.73), CLX: 99.83 (+0.33), BBY: 34.41 (+0.27)

Shares of CLX Up 10.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 27, 10:06AM CDT
SmarTrend identified an Uptrend for Clorox (NYSE:CLX) on September 19th, 2014 at $90.35. In approximately 1 month, Clorox has returned 10.03% as of today's recent price of $99.41.
CLX: 99.83 (+0.33)

InvestorsObserver releases comments on Wal-Mart, Facebook, ConocoPhillips, AmerisourceBergen, and Clorox
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver.com releases its Stocks To Watch guide.
ABC: 86.90 (+1.49), CLX: 99.83 (+0.33), FB: 73.88 (-1.11), COP: 70.56 (-1.59), WMT: 76.28 (+0.01)

Cleaning Industry Professionals Would Rather Clean Up Bodily Fluids than Tackle Urine Stains and Odors in Public Restrooms, According to Survey
PR Newswire - Mon Oct 27, 8:00AM CDT
Most people have a "get in and get out" strategy when it comes to using public restrooms and do not consider what kind of maintenance is put into these facilities on a daily basis. With restroom maintenance likely to be a topic discussed at the ISSA/INTERCLEAN conference in Orlando from November 4-7, Clorox Professional Products Company partnered with ISSA, the leading trade association for the cleaning industry worldwide, to uncover the "secrets from the stalls" and get the dirt about cleaning industry professionals' challenges and tough jobs in the restroom.
CLX: 99.83 (+0.33)

Nike Still Gaining on Strong Q1, Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 12:47PM CDT
Shares of the athletic apparel, footwear and accessories retailer, Nike Inc. (NKE) reached a new 52-week high of $90.70 on Oct 21, before closing a notch lower at $90.64.
LB: 72.44 (+0.32), CLX: 99.83 (+0.33), NKE: 93.45 (+0.48), JWN: 72.54 (-0.07)

L Brands Attains 52-Week High, Initiatives Pays Off - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 12:40PM CDT
L Brands, Inc. (LB) hit a 52-week high of $70.80 on Oct 21 before closing a notch lower at $70.35, reflecting a year-to-date return of nearly 18.4%.
LB: 72.44 (+0.32), CLX: 99.83 (+0.33), NKE: 93.45 (+0.48), JWN: 72.54 (-0.07)

Will B&G Foods (BGS) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 3:55PM CDT
B&G Foods, Inc. (BGS) is set to report third-quarter fiscal 2014 results on Oct 21, after the market closes.
POST: 37.92 (+0.42), CLX: 99.83 (+0.33), BGS: 29.18 (-0.28), SVU: 8.53 (-0.10)

Will V.F. Corporation (VFC) Beat Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 11:50AM CDT
We expect the footwear and apparel retailer V.F. Corporation (VFC) to beat expectations when it reports third-quarter 2014 results before the market opens on Oct 20.
UA: 65.99 (+0.41), CLX: 99.83 (+0.33), VFC: 67.90 (+0.22), NYT: 12.94 (+0.10)

Emulate Audacious Executives To Become A Game Changer
at Investor's Business Daily - Tue Oct 14, 12:50PM CDT
Executives and their companies need to take risks or chance being left behind. That's from Linda Rottenberg, author of "Crazy Is a Compliment: The Power of Zigging When Everyone Else Zags." "To survive, we all need to continually reinvent ourselves,"...
SBUX: 76.10 (+0.54), WDFC: 76.79 (+0.12), AMZN: 305.72 (+0.26), T: 34.84 (unch), F: 13.99 (-0.10), CLX: 99.83 (+0.33), WMT: 76.28 (+0.01), GM: 31.18 (-0.22), PG: 87.38 (+0.11), UL: 39.95 (-0.28), MSFT: 47.44 (+0.49), AAPL: 109.40 (+1.40)

Critical Alerts For Apple, Darden Restaurants, Myriad Genetics, Clorox and Ballard Power Systems Released By InvestorsObserver
PR Newswire - Mon Oct 13, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AAPL, DRI, MYGN, CLX and BLDP.
BLDP: 2.95 (+0.15), MYGN: 39.48 (-0.01), CLX: 99.83 (+0.33), AAPL: 109.40 (+1.40), DRI: 51.98 (+0.20)

The Clorox Company Releases 2014 Integrated Report; Reviews Financial, Environmental, Social and Governance Performance Against 2020 Strategy
Marketwired - Mon Oct 13, 7:30AM CDT
The Clorox Company (NYSE: CLX) has released its 2014 integrated annual report -- Powered by Value -- which reviews the company's financial, environmental, social and governance performance in the context of its 2020 Strategy.
CLX: 99.83 (+0.33)

SmarTrend Watching for Potential Pullback in Shares of Clorox After 2.17% Gain
Comtex SmarTrend(R) - Wed Oct 08, 5:24PM CDT
Clorox (NYSE:CLX) traded in a range yesterday that spanned from a low of $96.75 to a high of $98.89. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $97.46 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CLX: 99.83 (+0.33)

Clorox Set to Possibly Pullback After Yesterday's Rally of 2.17%
Comtex SmarTrend(R) - Wed Oct 08, 5:24PM CDT
Clorox (NYSE:CLX) traded in a range yesterday that spanned from a low of $96.75 to a high of $98.89. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $97.46 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CLX: 99.83 (+0.33)

Clorox Company (CLX) Stock Research Links

CLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading